搜索
Quanterix Corp
QTRX添加自选
4.330USD
-0.010-0.23%
收盘 07/02, 13:00（美东）报价延迟15分钟
203.77M总市值
亏损市盈率 TTM
关键数据
4.380今开
4.440最高
456.29K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.97%换手率
4.340昨收
4.220最低
1.42M成交额
亏损市盈率静
0.72市净率
0.00%股息率 TTM
-27.30%ROA
8.77052周最高
0.53量比
-38.53M净利润
47.06M总股本
-2.3568每股收益TTM
1.37Beta
-34.81%ROE
3.36052周最低
5.07%振幅
42.75%毛利率
203.77M总市值
2.97回报/风险
4.79%风险率
TradingKey Quanterix Corp股票评分
单位: USD 更新时间: 2026-07-02操作建议
Quanterix Corp当前公司基本面数据相对健康，增长潜力较大。当前估值合理，在医疗设备与耗材行业排名100/204位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价4.33。中期看，股价处于上升通道。近一个月，市场表现较强，技术面和基本面综合得分较高，较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
Quanterix Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
Quanterix Corp亮点
亮点风险
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
利润高增长
公司净利润处于行业前列，最新年度总收入138.90M美元
估值高估
公司最新PE估值-1.84，处于3年历史高位
机构减仓
最新机构持股42.63M股，环比减少10.46%
史蒂文·科恩持仓
明星投资者史蒂文·科恩持仓，最新持仓市值123.87K
分析师目标
根据
3
位分析师
持有
评级
4.333
目标均价
-0.15%
涨幅空间
Quanterix Corp新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Quanterix Corp简介
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
公司代码QTRX
公司Quanterix Corp
CEOToloue (Masoud)
网址https://www.quanterix.com/
相关品种
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%热门品种
常见问题
Quanterix Corp(QTRX)的当前股价是多少？
Quanterix Corp(QTRX)的当前股价是 4.33。
Quanterix Corp的股票代码是什么？
Quanterix Corp的股票代码是QTRX。
Quanterix Corp股票的52周最高点是多少？
Quanterix Corp股票的52周最高点是8.77。
Quanterix Corp股票的52周最低点是多少？
Quanterix Corp股票的52周最低点是3.36。
Quanterix Corp的市值是多少？
Quanterix Corp的市值是203.77M。
现在Quanterix Corp(QTRX)的股票是买入、持有还是卖出？
根据分析师评级，Quanterix Corp(QTRX)的总体评级为signal_hold，目标价格为4.33。
Quanterix Corp(QTRX)股票的每股收益（EPS TTM）是多少
Quanterix Corp(QTRX)股票的每股收益（EPS TTM）是-2.51。